| Dr Julia O Baltz, MD | |
|
1672 S County Trl Ste 101, East Greenwich, RI 02818-5099 | |
| (401) 885-7546 | |
| (401) 885-6640 |
| Full Name | Dr Julia O Baltz |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 1672 S County Trl Ste 101, East Greenwich, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588082200 | NPI | - | NPPES |
| 110115620A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 16273 (Rhode Island) | Secondary |
| 207N00000X | Dermatology | 275273 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Professionals Inc | 9234283953 | 16 |
| Dermatology Professionals Llc | 1254653355 | 8 |
News Archive
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità, Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
Researchers have suggested that repeated vaccination against SARS-CoV-2 may enable previously uninfected individuals to cope with viral variants.
› Verified 5 days ago
| Entity Name | Dermatology Professionals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902040835 PECOS PAC ID: 9234283953 Enrollment ID: O20090814000486 |
News Archive
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità, Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
Researchers have suggested that repeated vaccination against SARS-CoV-2 may enable previously uninfected individuals to cope with viral variants.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julia O Baltz, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Dr Julia O Baltz, MD 1672 S County Trl Ste 101, East Greenwich, RI 02818-5099 Ph: (401) 885-7546 |
News Archive
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità, Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.
Researchers have suggested that repeated vaccination against SARS-CoV-2 may enable previously uninfected individuals to cope with viral variants.
› Verified 5 days ago
Dr. John B Kelly Iii, MD/PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1672 S County Trl, East Greenwich, RI 02818 Phone: 401-885-7546 Fax: 401-885-6640 | |
Jessica Corwin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1672 S County Trl Ste 202, East Greenwich, RI 02818 Phone: 401-885-4100 Fax: 401-885-4130 | |
Dr. Nathaniel Josef Jellinek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1672 S County Trl, Suite 101, East Greenwich, RI 02818 Phone: 404-885-6647 Fax: 401-885-6639 | |
Dr. Lynn E Iler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1672 S County Trl, Suite 101, East Greenwich, RI 02818 Phone: 401-885-7546 Fax: 401-885-6640 | |
Caroline Chang, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5586 Post Rd Unit 6, East Greenwich, RI 02818 Phone: 401-398-2500 Fax: 401-398-2599 | |
Valerie Ann Tokarz, D.O., FAAD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1672 S County Trl, Ste. 101, East Greenwich, RI 02818 Phone: 401-885-7546 Fax: 401-885-6658 | |
Alexandra Leonard, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1672 S County Trl, East Greenwich, RI 02818 Phone: 401-885-7546 |